Avacta Announces Presentations at AACR | 26-Mar-2025 | 07:00 | RNS |
Avacta Completes Launch Diagnostics Sale | 25-Mar-2025 | 07:00 | RNS |
Avacta to Present at Leerink Healthcare Conference | 10-Mar-2025 | 07:00 | RNS |
Avacta announces data update for AVA6000 | 07-Mar-2025 | 08:40 | RNS |
Avacta to sell Launch Diagnostics | 07-Mar-2025 | 07:42 | RNS |
Appointment of Joint Broker | 04-Feb-2025 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 21-Jan-2025 | 15:09 | RNS |
Avacta Announces Data from AVA6000 Phase 1 trial | 16-Jan-2025 | 07:00 | RNS |
Avacta Appoints Chief Financial Officer | 13-Jan-2025 | 07:00 | RNS |
Completion of Dose Escalation and RDE Arms | 12-Dec-2024 | 07:00 | RNS |
R&D Spotlight focusing on pipeline advances | 30-Oct-2024 | 07:00 | RNS |
Block Listing Six Monthly Return | 28-Oct-2024 | 07:00 | RNS |
Avacta Reports Pipeline Avances at EORTC | 24-Oct-2024 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 21-Oct-2024 | 16:00 | RNS |
Avacta and Tempus Enter Strategic Collaboration | 21-Oct-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 39.39p |
Change Today | 1.64p |
% Change | 4.33 % |
52 Week High | 82.50 |
52 Week Low | 33.75 |
Volume | 460,463 |
Shares Issued | 376.22m |
Market Cap | £148.17m |
Beta | 0.02 |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
10:20 | 1,000 @ 40.00p |
10:19 | 604 @ 39.40p |
10:18 | 2,395 @ 39.40p |
10:15 | 50,000 @ 39.10p |
10:12 | 208 @ 39.45p |
You are here: research